Family Medicine Doctors in Atmore, AL Accepting Medicare
8 Family Medicine doctors found. Showing 1 - 8
 William Shane Harigel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 |
 Frances Delaine Salter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 6th Ave, Atmore, AL 36502 Phone: 251-368-8999 Fax: 251-368-8887 |
Dr. Priscilla Beverly Durand-mitchelle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 706 E Laurel St, Atmore, AL 36502 Phone: 251-368-5117 Fax: 251-368-4021 |
Sheldon Jon Harigel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Drive, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 |
Dr. Jonathan Edward Yoder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 402 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-7974 Fax: 251-368-5973 |
Layla Renee Lundquist-smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 609 E. Laurell Street, Atmore, AL 36502 Phone: 251-368-6906 |
John P Mcguinness, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-6221 |
Parker Gene Estvold, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5811 Jack Springs Rd, Atmore, AL 36502 Phone: 251-368-8630 |
News Archive
FDA grants permission to market new Seeker System for screening rare metabolic disorders in newborns
The U.S. Food and Drug Administration today permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders (LSDs) in newborns.
Researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer
A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.
UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia
Though the drug levodopa can dramatically improve Parkinson's disease symptoms, within five years one-half of the patients using L-DOPA develop an irreversible condition - involuntary repetitive, rapid and jerky movements.
FDA Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device, intended for the endovascular treatment of large or giant wide-necked intracranial aneurysms in the cavernous and paraclinoid regions of the internal carotid artery.
› Verified 7 days ago